Navigation Links
Valeant Pharmaceuticals Announces Redemption of 4.0% Convertible Subordinated Notes Due 2013
Date:4/20/2011

MISSISSAUGA, Ontario, April 20, 2011 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) today announced that it will redeem all of the outstanding 4.0% Convertible Subordinated Notes due 2013 (the "Notes") of its wholly-owned subsidiary, Valeant Pharmaceuticals International, on May 20, 2011 (the "Redemption Date").  The notice of redemption was distributed to holders of the Notes on April 20, 2011.

On and after May 20, 2011, the Notes will no longer be deemed outstanding, interest will cease to accrue thereon, and all rights of the holders will cease, except for the right to receive the redemption price, without interest thereon.

The current conversion price is $12.65.  The Notes called for redemption may be converted at any time before the close of business on May 19, 2011 but may not be converted on or after the Redemption Date unless the Company fails to pay the redemption price.

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.

Caution Regarding Forward-Looking Information and "Safe Harbor" Statement

This press release may contain forward-looking statements, including, but not limited to, our financing plans. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking sta
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Regulatory Update - GSK and Valeant Respond to FDA on ezogabine
2. Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors
3. Valeant Pharmaceuticals Files Presentation for Cephalon Stockholders
4. Valeant Pharmaceuticals Files Preliminary Consent Solicitation Statement With the SEC
5. Promius Pharma and Valeant Form Collaboration to Market Cloderm® Cream in the United States
6. Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash
7. GSK and Valeant Receive European Authorisation for Trobalt (retigabine)
8. Valeant Pharmaceuticals Extends Contract with J. Michael Pearson as CEO and Appoints Him as Chairman of the Board
9. Valeant Pharmaceuticals Completes Acquisition of PharmaSwiss S.A.
10. Valeant Announces Pricing of Senior Notes
11. Valeant Launches Senior Notes Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... , July 27, 2015 Syneron ... ) , a global market leader in the aesthetic ... Korean Ministry of Food and Drug Safety (MFDS) regulatory ... clearance, the Company can fulfill PicoWay orders from its ... Korea anticipated later in the third quarter 2015. ...
(Date:7/27/2015)... 2015 Prospects for Development, Manufacturing ... Discover Top Companies, Revenue Prospects Now, Benefiting Your Influence ... of generic medicines ? Visiongain ,s new ... study lets you discover results, trends, opportunities and revenue ... For leading producers and marketers of generic drugs, you ...
(Date:7/27/2015)...  Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... chronic pain, today announced that it has filed ... Canada to conduct a multiple ascending dose ... novel, N-methyl-D-aspartate (NMDA) receptor antagonist being developed for ... are very encouraged by the initial results from ...
Breaking Medicine Technology:Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 2Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 3Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 4Pharma Leader Series: Top Generic Drug Producers - Leading Companies and Forecasts 2015-2025 2Pharma Leader Series: Top Generic Drug Producers - Leading Companies and Forecasts 2015-2025 3Pharma Leader Series: Top Generic Drug Producers - Leading Companies and Forecasts 2015-2025 4Pharma Leader Series: Top Generic Drug Producers - Leading Companies and Forecasts 2015-2025 5Pharma Leader Series: Top Generic Drug Producers - Leading Companies and Forecasts 2015-2025 6Pharma Leader Series: Top Generic Drug Producers - Leading Companies and Forecasts 2015-2025 7Pharma Leader Series: Top Generic Drug Producers - Leading Companies and Forecasts 2015-2025 8Pharma Leader Series: Top Generic Drug Producers - Leading Companies and Forecasts 2015-2025 9Relmada Therapeutics Announces Filing of Clinical Trial Application in Canada for Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist d-Methadone 2Relmada Therapeutics Announces Filing of Clinical Trial Application in Canada for Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist d-Methadone 3
... 2011 Awarepoint Corporation , the leading ... healthcare, announced today that it received Frost & ... Competitive Strategy Leadership Award .  The award ... RTLS and workflow automation solutions that significantly differentiates ...
... 29, 2011 A pathway activated in cancer plays ... 2 diabetes, according to a study by researchers at ... the cellular response to glucose provides a unifying theme ... diabetes risk. The multi-institutional research team led ...
Cached Medicine Technology:Awarepoint Corporation Receives Frost & Sullivan's 2011 North American RFID and RTLS Healthcare Competitive Strategy Leadership Award 2Awarepoint Corporation Receives Frost & Sullivan's 2011 North American RFID and RTLS Healthcare Competitive Strategy Leadership Award 3Unexpected Link Between Cancer and Diabetes Revealed 2Unexpected Link Between Cancer and Diabetes Revealed 3
(Date:7/27/2015)... ... ... Dr. Robert G. Schwartz , principal of Greenville, SC-based Piedmont Physical ... Centers in order to offer his patients a new system of care utilizing laser ... , Peripheral neuropathy is a disease caused by damage to the peripheral nerves, and ...
(Date:7/27/2015)... ... 28, 2015 , ... Conducting Advanced Root Cause Analysis CAPA ... Quality of Investigations , **Presented by FDAnews and Learning Plus**, Sept. 16-17, 2015 ... the #1 reason for 483 observations since 1997! , The FDA's enforcement plan ...
(Date:7/27/2015)... ... ... The National Association of Professional Women (NAPW) honors Deana ... Circle. She is recognized with this prestigious distinction for leadership in healthcare. With more ... networking organization exclusively for professional women. , “I’m pleased to recognize Deana with this ...
(Date:7/27/2015)... ... July 28, 2015 , ... ... Baum- Lappe as a 2015 Professional Woman of the Year. Ms. Baum-Lappe ... most-recognized networking organization of professional women in the country, spanning virtually every industry ...
(Date:7/27/2015)... Falls Church, VA (PRWEB) , ... July 27, ... ... Quality and Compliance From Step One, **FDAnews Webinar**, Aug. 13, 2015 — 1:30 ... operating procedures are one of the first things FDA investigators will look at ...
Breaking Medicine News(10 mins):Health News:Piedmont Physical Medicine & Rehabilitation, P.A. Partners with Realief® Neuropathy Centers to Offer Peripheral Neuropathy Laser Treatment 2Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 2Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 3Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 4Health News:NAPW Inducts Deana Skidmore, Assistant Director of Nursing at Wilton Meadows Rehablilitation and Health Care Center, Into its VIP Woman of the Year Circle 2Health News:NAPW Inducts Gilda Baum-Lappe, Journalist / Correspondent of Hollywood Foreign Press Association Into its VIP Woman of the Year Circle 2Health News:FDAnews Announces — Writing Effective Standard Operating Procedures: Ensure Quality and Compliance From Step One Webinar, Aug. 13, 2015 2Health News:FDAnews Announces — Writing Effective Standard Operating Procedures: Ensure Quality and Compliance From Step One Webinar, Aug. 13, 2015 3Health News:FDAnews Announces — Writing Effective Standard Operating Procedures: Ensure Quality and Compliance From Step One Webinar, Aug. 13, 2015 4
... A new organization, the American Society of Medical Doctors ... on issues that affect their relationship with patients. The first ... the organization will fight proposals for a government-run health care ... , "If these proposals are enacted, the American health ...
... of the International Diabetes Federation (IDF) is now open. ... 18-22, 2009 at Palais des Congrs de Montral (Montral ... world,s largest medical conferences, the 20th World Diabetes Congress ... level speakers and more than 200 national diabetes associations ...
... For more than 30 years, consumers have benefited from the ... effects of the sun, including sun burn, premature skin aging, ... efficacy of sunscreen products have been thoroughly studied and tested ... is an extensive body of credible scientific research that demonstrates ...
... the negative effect, study finds , THURSDAY, July 2 (HealthDay ... of early death, says a new study that challenges findings ... on nearly 44,000 men found that other major factors -- ... social circumstances as an adult -- nullify the effect of ...
... Six Ways to Chill Out This Summer , , SAN FRANCISCO, ... in the form of Metromint ( www.metromint.com ), the all-natural ... cooling sensation in every sip and is the perfect refreshment to beat ... tips for staying hydrated during the hot summer months: , , ...
... Genetics, Inc. (NYSE Amex: ILI ) announced today that ... Alan James Group assets of its subsidiary AJG Brands, Inc. to ... million in cash. The transaction was completed following the close of ... Alan James Group business saw an increase in sales during the ...
Cached Medicine News:Health News:American Society of Medical Doctors Established to Protect the Bond Between Physicians and Patients; Organizing Doctors to Oppose Government-Run Health Care 2Health News:Statement by John Bailey, Chief Scientist The Personal Care Products Council, Response to EWG's 2009 Sunscreen Report 2Health News:Statement by John Bailey, Chief Scientist The Personal Care Products Council, Response to EWG's 2009 Sunscreen Report 3Health News:Statement by John Bailey, Chief Scientist The Personal Care Products Council, Response to EWG's 2009 Sunscreen Report 4Health News:Statement by John Bailey, Chief Scientist The Personal Care Products Council, Response to EWG's 2009 Sunscreen Report 5Health News:Study Casts Doubt on Low IQ's Role in Early Death 2Health News:Nationwide Heat Wave Finally Gives Way To Cooling Trend 2Health News:Nationwide Heat Wave Finally Gives Way To Cooling Trend 3Health News:Interleukin Genetics Announces Strategic Divestment of Alan James Group 2
... camera system for high resolution photomicrography. The ... of the highest color fidelity, resolution and ... expect perfect images due to many unique ... innovative readout modes. The Leica DFC480 is ...
This compact photomicrographic system assures simple operation to achieve the exposure accuracy required for sophisticated photomicrography in most research and clinical environments....
... Geometric Data Hemastainer. Formulated to ... quality control tested on human ... staining and absence of precipitate. ... a minimum of eight hours ...
... Stat Stain is ideal for stat, routine ... blood smears (10-15 seconds) and bone marrow ... finely dispersed stain particles which yield excellent ... many of the steps involved in the ...
Medicine Products: